BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17184181)

  • 21. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.
    Robertson RP; Harmon J; Tran PO; Tanaka Y; Takahashi H
    Diabetes; 2003 Mar; 52(3):581-7. PubMed ID: 12606496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?
    Evans JL; Goldfine ID; Maddux BA; Grodsky GM
    Diabetes; 2003 Jan; 52(1):1-8. PubMed ID: 12502486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on diabetes mellitus.
    Korc M
    Dis Markers; 2004; 20(3):161-5. PubMed ID: 15502249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Glucose Tolerance and Pancreatic Beta Cell Function by Low Dose Aspirin in Hyperglycemic Insulin-Resistant Type 2 Diabetic Goto-Kakizaki (GK) Rats.
    Amiri L; John A; Shafarin J; Adeghate E; Jayaprakash P; Yasin J; Howarth FC; Raza H
    Cell Physiol Biochem; 2015; 36(5):1939-50. PubMed ID: 26202354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of oxidative stress in suppression of insulin biosynthesis under diabetic conditions.
    Kaneto H; Matsuoka TA
    Int J Mol Sci; 2012 Oct; 13(10):13680-90. PubMed ID: 23202973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of feline diabetes mellitus.
    Lutz TA; Rand JS
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes.
    Ihara Y; Toyokuni S; Uchida K; Odaka H; Tanaka T; Ikeda H; Hiai H; Seino Y; Yamada Y
    Diabetes; 1999 Apr; 48(4):927-32. PubMed ID: 10102716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes-induced Proteome Changes Throughout Development.
    Johar D; Ahmed SM; El Hayek S; Al-Dewik N; Bahbah EI; Omar NH; Mustafa M; Salman DO; Fahmey A; Mottawea M; Azouz RAM; Bernstein L
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):732-743. PubMed ID: 31038056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?
    Rehman K; Akash MS
    J Biomed Sci; 2016 Dec; 23(1):87. PubMed ID: 27912756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.
    Hasnain SZ; Borg DJ; Harcourt BE; Tong H; Sheng YH; Ng CP; Das I; Wang R; Chen AC; Loudovaris T; Kay TW; Thomas HE; Whitehead JP; Forbes JM; Prins JB; McGuckin MA
    Nat Med; 2014 Dec; 20(12):1417-26. PubMed ID: 25362253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in the role of oxidative stress in the pathogenesis of type 2 diabetes].
    Ren CJ; Zhang Y; Cui WZ; Mu ZM
    Sheng Li Xue Bao; 2013 Dec; 65(6):664-73. PubMed ID: 24343725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes.
    Tanaka S; Aida K; Nishida Y; Kobayashi T
    Endocr J; 2013; 60(7):837-45. PubMed ID: 23774118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heme oxygenase system and type-1 diabetes.
    Tiwari S; Ndisang JF
    Curr Pharm Des; 2014; 20(9):1328-37. PubMed ID: 23978102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes.
    Gorogawa Si; Kajimoto Y; Umayahara Y; Kaneto H; Watada H; Kuroda A; Kawamori D; Yasuda T; Matsuhisa M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2002 Jul; 57(1):1-10. PubMed ID: 12007724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications].
    Lopes JP; Oliveira SM; Soares Fortunato J
    Acta Med Port; 2008; 21(3):293-302. PubMed ID: 18674421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
    Cerasi E; Ktorza A
    Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in Drosophila.
    Gupta HP; Jha RR; Ahmad H; Patel DK; Ravi Ram K
    Free Radic Biol Med; 2019 Sep; 141():461-474. PubMed ID: 31319158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Protective effect of rosiglitazone sodium on islet beta-cell of STZ induced diabetic rats through JNK pathway].
    Liu GY; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):430-4. PubMed ID: 19626998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.